Semaglutide headaches: the trial numbers and the questions worth asking

Start with the headache, not the explanation

A headache after starting semaglutide is worth reporting, but the timing does not settle its cause. My first question would be whether this feels like a familiar headache or something distinctly different. That is a more useful starting point than searching for a universal number of days to wait. MedlinePlus advises immediate help for a sudden explosive headache or one accompanied by neurological changes. Call 911 for those emergency symptoms. Do not wait for an online prescriber message or assume that being on a new treatment explains a severe new symptom.^[2]

What the 14% figure actually describes

The Wegovy label reports headache in 14% of adults receiving the studied 2.4 mg weekly injection and 10% receiving placebo. That is a four-percentage-point difference. These are adult weight-management trial groups, not a headache rate for every semaglutide formulation or dose. I would keep the placebo column beside the treatment column whenever citing this number: it helps prevent turning every headache during treatment into a medication-caused event. The table describes how often a symptom was reported, not which explanation fits an individual reader.^[1]

Low blood sugar is a specific question, not the default answer

NIDDK lists headache among possible low-blood-glucose symptoms, alongside shakiness, hunger, dizziness and confusion. Insulin and medicines that stimulate insulin release make this question particularly relevant. If you have a glucose-monitoring and low-glucose treatment plan, follow it and tell your care team about the episode. A headache alone cannot establish a low reading. When contacting the clinician, provide the actual reading if available and name all diabetes medicines. Saying only that you take semaglutide leaves out information needed to judge the situation.^[3]

Look at fluid intake and the rest of the week

Vomiting, diarrhea and inadequate fluid intake can lead to dehydration. MedlinePlus identifies reduced urination, dark urine, dry mouth and dizziness as signs to notice; confusion, fainting or no urination warrants immediate help. Record those observations rather than concluding that a headache must be a hydration problem. A useful message might distinguish a headache on an otherwise ordinary day from one following repeated vomiting and difficulty drinking. Those are different accounts for your clinician to assess. There is no single water target in this article because individual fluid needs differ.^[4] Read more: GLP-1 dehydration and kidney warnings

Keep a short record that a clinician can actually use

MedlinePlus recommends a headache diary covering timing, food and drink, sleep, duration and what helped. I would add the exact medication name and the date of the most recent prescribed dose change to that conversation. Keep observations separate from theories: “started at 3 p.m., lasted two hours” is clearer than “my dose is too strong.” You do not need an elaborate spreadsheet. A few consistent entries are easier to discuss than a long retrospective story, and the goal is to support an assessment rather than prove a conclusion in advance.^[2]

Do not build a new regimen around a search result

Before adding a pain medicine or repeatedly taking one you already use, ask a pharmacist or clinician what fits your other medicines and health history. MedlinePlus advises discussing pain-medicine use on three or more days each week. I would also ask who will handle follow-up if the headache keeps returning: the GLP-1 prescriber, primary care or an existing headache clinician. Make that responsibility explicit. A search article can help organize questions, but it cannot tell you to lower a dose, stretch the interval or use a particular drug combination.^[2]

Ask for a plan instead of a reassurance slogan

“Is this expected?” is understandable, but it may produce a vague answer. Try three more precise questions: what other explanations need consideration, what change should prompt urgent evaluation, and when should I contact you again if it continues? If eating has become difficult because of nausea, mention that separately rather than using headache as shorthand for the entire week. I prefer a documented follow-up plan to an assurance that side effects are normal. Common and acceptable are not the same judgment, especially when a symptom is disrupting work, sleep or daily tasks. Read more: What nausea trial rates do and do not show

My reading of the evidence

The useful conclusion is modest: headache was reported more often in one studied Wegovy injection group than with placebo, while the cause of a particular headache still requires its own assessment. I would not rank telehealth companies by that trial percentage or promise that switching websites would solve the problem. For a reader already in treatment, access to a clinician who can respond to a clearly described symptom matters more than another promotional offer. Keep the symptom record, obtain a specific follow-up plan and give urgent symptoms priority over routine messaging.^[1]

Continue your research

• Semaglutide diarrhea: what the rates mean and when to call
• Semaglutide sulfur burps: what is known, and what gets overstated